NCT07186153View on ClinicalTrials.gov

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

November 1, 2026

Conditions

SGLT 2 Inhibitors

Interventions

DRUG

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor

evaluate and follow-up left atrial volume, diastolic function by 2D echocardiography and left atrial strain parameters using speckle-tracking echocardiography in patients with type 2 diabetes mellitus (T2DM) after treatment with SGLT2 inhibitors

All Listed Sponsors

lead

Assiut University

OTHER

NCT07186153 - Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients | Biotech Hunter | Biotech Hunter